methotrexate has been researched along with Scleroderma, Localized in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.65) | 18.7374 |
1990's | 4 (3.54) | 18.2507 |
2000's | 19 (16.81) | 29.6817 |
2010's | 59 (52.21) | 24.3611 |
2020's | 28 (24.78) | 2.80 |
Authors | Studies |
---|---|
Kromer, C; Langer, N; Mitterlechner, L; Mössner, R; Schön, MP | 1 |
Meza-Romero, R; Moll-Manzur, C; Ramírez-Cornejo, C; Vera-Kellet, C; Wortsman, X | 1 |
Conejero Del Mazo, R; Fuentelsaz Del Barrio, MV; Genzor Ríos, C; López Campos, M; Valer Martínez, A; Vázquez Sánchez, M | 1 |
Abduelmula, A; Luca, NJ; Prajapati, VH; Rankin, BD; Riaz, S; Ross, N | 1 |
Li, SC | 1 |
Ding, CH; Fang, F; Feng, WX; Ge, M; Gong, S; Li, JW; Xiang, X; Zhang, N; Zhuo, XW | 1 |
De, D; Gupta, A; Handa, S; Jindal, AK; Kaushik, A; Loganathan, SK; Mahajan, R; Pandiarajan, V; Rawat, A; Singh, S; Sudhakar, M; Suri, D | 1 |
Li, J; Liu, H; Zhang, F; Zhao, Q | 1 |
Bakrin, IH; Bin Ahmad, MZ; Lim, SC; Mat Nasir, N; Md Yasin, M; Yusof, ANM | 1 |
Ayaz, NA; Bağlan, E; Bülbül, M; Çağlayan, Ş; Çakan, M; Çakmak, F; Kızıldağ, Z; Makay, B; Özdel, S; Öztürk, K; Sözeri, B; Ünsal, ŞE; Yener, GO | 1 |
Andrews, T; Becker, ML; Dedeoglu, F; Ferguson, PJ; Fuhlbrigge, RC; Higgins, GC; Hong, SD; Ibarra, MF; Laxer, RM; Li, SC; Mason, T; Pope, E; Rabinovich, CE; Stewart, K; Torok, KS | 1 |
Foeldvari, I | 4 |
Dvorakova, V; McCarthy, S; Murphy, M; Murray, D; Watson, R | 1 |
Brandling-Bennett, H; Do, N; Ringold, S; Sullivan, E | 1 |
Atherton, D; Denton, CP; Harper, JI; Howell, KJ; Theiler, M; Waelchli, R; Weibel, L; Woo, P | 1 |
Arthur, M; Cardones, AR; Femia, A; Fernandez, AP; Fett, NM; Florez-Pollack, S; Gaffney, R; Houser, J; Jacobe, H; Knabel, D; Kunzler, E; Latour, E; Laumann, A; Leung, N; Lo, K; Pappas-Taffer, LK; Prasad, S; Sharma, S; Stern, MJ; Tkachenko, E; Vleugels, RA; Yu, JM; Zhao, J | 1 |
Agazzi, A; Fadanelli, G; Martini, G; Meneghel, A; Vittadello, F; Zulian, F | 1 |
De, D; Handa, S; Kaushik, A; Mahajan, R | 1 |
Georgiou, S; Gkentzi, D; Melachrinou, M; Plachouri, KM; Ravazoula, P | 1 |
Tirelli, F; Zulian, F | 1 |
Brockman, R; Fett, N; Greiling, TM; Leitenberger, S; Wills, A | 1 |
Culpo, R; Martini, G; Meneghel, A; Saggioro, L; Vittadello, F; Zulian, F | 1 |
Bassi, A; Belloni Fortina, A; Bonamonte, D; Brazzelli, V; Cambiaghi, S; DI Lernia, V; Diociaiuti, A; El Hachem, M; Neri, I; Patrizi, A; Pepe, P; Schena, D; Virdi, A | 1 |
Buckley, M; Ede, KC; Edelheit, B; Ishaq, SS; Li, SC; Liu, C; Rabinovich, CE; Torok, KS | 1 |
Brown, RA; Messenger, EA; Novoa, RA; Pepper, MA; Theparee, T | 1 |
Weibel, L | 2 |
Adly, M; Lethebe, BC; Luca, NJC; Milovanova, K; Prajapati, VH; Stevenson, R | 1 |
Alfagemeb, F; Laverde-Saad, A; Lopez-Negrete, E; Roustan, G | 1 |
Ashworth, JL; Chieng, AS; Kehdi, E; Lenassi, E; Vassallo, G | 1 |
Atzori, L; Ferreli, C; Pilloni, L; Pinna, AL; Rongioletti, F; Venturi, M | 1 |
Jorizzo, JL; Rattanakaemakorn, P | 1 |
Akasaka, E; Jin, K; Korekawa, A; Matsuzaki, Y; Nakano, H; Sawamura, D | 1 |
Binstadt, BA; Correll, CK; Hobday, PM; Kashem, SW; Maguiness, SM; Vehe, RK | 1 |
Cimaz, R; Foeldvari, I; Lopez, JA; Marrani, E; Simonini, G | 1 |
Zulian, F | 1 |
Anderson, LE; Knight, AM; Kreiger, PA; Licht, DJ; Treat, JR | 1 |
Kurzinski, KL; Torok, KS; Zigler, CK | 1 |
Alberto Cardenas-De La Garza, J; Cuellar-Barboza, A; Daniel Villarreal-Villarreal, C; Gomez-Flores, M; Herz-Ruelas, ME; Ocampo-Candiani, J; Welsh, O | 1 |
Gan, JJL; Iqbal, T; Koleva, E; Kuah, CY | 1 |
Benamara-Levy, M; Bodemer, C; Dionne, MC; Le Sache de Peufheiloux, L; Leducq, S; Maruani, A; Samimi, M | 1 |
Hsu, T; Lee, LW; Lu, MC; Shyur, SD | 1 |
Chiu, Y; Nocton, J; Zhang, A | 1 |
Aubert, H; Barbarot, S; Bégon, E; Belot, A; Boccara, O; Boralevi, F; Bourrat, E; Cabrera, N; Chiaverini, C; Droitcourt, C; Duriez-Lasek, A; Hardy, J; Hubiche, T; Lerosey, MG; Mahé, E; Mallet, S; Mazereeuw-Hautier, J; Phan, A; Piram, M | 1 |
Anton, J; Avcin, T; Baildam, EM; Boros, C; Chaitow, J; Constantin, T; Culpo, R; Foeldvari, I; Kasapcopur, O; Knupp Feitosa de Oliveira, S; Pilkington, CA; Russo, R; Saad Magalhães, C; Sperotto, F; Toplak, N; van Royen, A; Vastert, SJ; Wulffraat, NM; Zulian, F | 1 |
Benson, P; Johnston, M; Morley, K | 1 |
Dal Pos, S; Martini, G; Rodeghiero, F; Zannin, ME; Zulian, F | 1 |
Andrews, T; Becker, ML; Dedeoglu, F; Feldman, BM; Ferguson, PJ; Fuhlbrigge, RC; Higgins, GC; Hong, S; Ibarra, MF; Laxer, RM; Li, SC; Mason, T; Pope, E; Punaro, M; Rabinovich, CE; Stewart, K; Torok, KS | 1 |
Albuquerque, JV; Andriolo, BN; Civile, VT; Lyddiatt, A; Trevisani, VF; Vasconcellos, MR | 1 |
Claussen, CD; Fierlbeck, G; Henes, J; Horger, M; Kötter, I; Schanz, S; Ulmer, A | 1 |
Cerci, FB; Jorizzo, JL; Koch, SB; Krowchuk, DP | 1 |
Agata, K; Akaba, M; Go, S; Hirose, A; Kashiwagi, Y; Kawashima, H; Mitsuhashi, Y; Nishimata, S; Tsuboi, R | 1 |
Cuffaro, G; Sperotto, F; Zulian, F | 1 |
Bielsa Marsol, I | 1 |
García-Romero, MT; Laxer, R; Pope, E; Taylor, G | 1 |
Haddad, E; Hatami, A; Marcoux, D; McCuaig, CC; Piram, M; Powell, J; Saint-Cyr, C | 1 |
Falcini, F; Garzitto, A; Kaloudi, O; Matucci Cerinic, M; Nacci, F; Porta, F; Prignano, F | 1 |
Gilmore, ES; Mathes, EF; Moon, A; Paller, AS; Polcari, I | 1 |
Jacobe, H; Patel, G; Strickland, A; Strickland, N | 1 |
De Haes, P; Hauben, E; Lambrechts, P; Teughels, W; Van der Veken, D | 1 |
Arias-Santiago, S; Lafèbre, SR; Magro-Checa, C; Orgaz-Molina, J; Raya, E; Rosales-Alexander, JL | 1 |
Bhise, V; Li, SC; Magrini, D; Moorthy, LN; Weiss, PF | 1 |
de Jong, EM; Hoppenreijs, EP; Knaapen, HK; Marsman, D; Mertens, JS; Radstake, TR; Seyger, MM; van de Kerkhof, PC | 1 |
de Jong, EM; Kievit, W; Mertens, JS; Radstake, TR; Seyger, MM; Thurlings, RM; van de Kerkhof, PC; van den Reek, JM | 1 |
Meyer, V; Sachse, MM; Wagner, G | 1 |
de Jong, EMGJ; Mertens, JS; Radstake, TRDJ; Seyger, MMB; Thurlings, RM | 1 |
Afsar, FS; Christen-Zaech, S; Hakim, MD; Paller, AS | 1 |
Byrne, A; Collins, S; Cox, D; Irvine, A; O' Regan, G; Watson, R | 1 |
Boezeman, JB; Creemers, MC; de Jong, EM; Kroft, EB; van den Hoogen, FH | 1 |
Jessop, S; Whitelaw, D | 1 |
Falcini, F; Girschick, H; Goldsmith, DP; Martini, G; Ramanan, AV; Zulian, F | 1 |
Feldman, BM; Haines, KA; Higgins, GC; Li, SC; O'Neil, KM; Punaro, MG | 1 |
Kawashima, H; Mitsuhashi, Y; Okubo, Y; Tsuboi, R; Uchiyama, M; Yamamoto, K | 1 |
Homey, B; Pierchalla, A; Schulte, KW | 1 |
Jacobe, HT; Saxton-Daniels, S | 1 |
Carneiro, S; Ramos-e-Silva, M; Vilela, FA | 1 |
Kagawa, T; Nakajima, H; Nakajima, K; Okazaki, M; Taniguchi, Y; Terada, Y | 1 |
Fett, N; Werth, VP | 1 |
Alessio, M; Belloni-Fortina, A; Cutrone, M; Falcini, F; Gerloni, V; La Torre, F; Martini, G; Martino, S; Paradisi, M; Patrizi, A; Perilongo, G; Podda, RA; Vallongo, C; Vittadello, F; Zulian, F | 1 |
Jacobe, HT; Zwischenberger, BA | 1 |
Choi, YJ; Kim, HO; Kim, HS; Lee, JY; Park, YM | 1 |
Baildam, EM; Bhushan, M; Ennis, H; Herrick, AL; Silman, AJ | 1 |
Chakkittakandiyil, A; Laxer, RM; Mirsky, L; O'Brien, C; Pope, E | 1 |
Kineston, D; Kwan, JM; Shumaker, PR; Uebelhoer, NS | 1 |
Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B | 1 |
Jeon, H; Kim, C | 1 |
Arkachaisri, T; Torok, KS | 1 |
Baszis, K; Becker, M; Campillo, S; Cartwright, V; Cidon, M; Dedeoglu, F; Ferguson, PJ; Fuhlbrigge, RC; Higgins, GC; Hong, S; Ilowite, NT; Inman, CJ; Jacobe, HT; Jerath, R; Lasky, A; Laxer, RM; Li, SC; O'Neil, KM; Pope, E; Rabinovich, CE; Torok, KS; Vora, S; Wallace, CA; Zeft, A | 1 |
Alessio, M; Belloni-Fortina, A; Cutrone, M; Gerloni, V; Martini, G; Martino, S; Patrizi, A; Vallongo, C; Vittadello, F; Zulian, F | 1 |
Lebeaux, D; Sène, D | 1 |
Kasapçopur, O; Ozkan, HC; Tüysüz, B | 1 |
Altmeyer, P; Breuckmann, F; Freitag, M; Kreuter, A; Rotterdam, S; Stuecker, M | 1 |
Altmeyer, P; Breuckmann, F; Freitag, M; Gambichler, T; Hoffmann, K; Kreuter, A; Rotterdam, S; Stuecker, M | 1 |
Athreya, BH; Cuttica, R; Esteves Hilário, MO; Feitosa de Oliveira, SK; Foeldvari, I; Garay, SM; Garcia-Consuegra, J; Harper, J; Higgins, GC; Laxer, R; Lepore, L; Lindsley, C; Machado, C; Martini, G; Moore, TL; Nelson, AM; Peserico, A; Punaro, MG; Silva, CA; Uziel, Y; Van Suijlekom-Smit, LW; Woo, P; Zulian, F | 1 |
Akin, E; Burnham, JM; Cron, RQ; Finkel, TH; Fitch, PG; Rettig, P; Yan, AC | 1 |
Altmeyer, P; Appelhans, C; Breuckmann, F; Brockmeyer, NH; Gambichler, T; Kreuter, A | 1 |
Hoshika, A; Ioi, H; Kashiwagi, Y; Kawashima, H; Ooi, T; Ookubo, Y; Sasamoto, M; Sato, S; Takekuma, K; Watanabe, C | 1 |
Da Dalt, L; de Oliveira, SK; Eichenfield, LF; Galea, P; Mazur-Zielinska, H; Punaro, MG; Ros, J; Vallongo, C; Zulian, F | 1 |
Harper, JI; Howell, KJ; Sampaio, MC; Visentin, MT; Weibel, L; Woo, P | 1 |
Tollefson, MM; Witman, PM | 1 |
Bono, W; Dupin, N | 1 |
Avallone, L; Battaglia, D; Bersani, G; Contaldo, I; Gaspari, S; La Torraca, I; Rigante, D; Stabile, A | 1 |
Hödl, S | 1 |
Chalmers, IM; Gough, J; Janzen, L; Jeffery, JR | 1 |
Cunningham, BB; Vierra, E | 1 |
Krafchik, BR | 1 |
Feldman, BM; Krafchik, BR; Laxer, RM; Uziel, Y; Yeung, RS | 1 |
de Jong, EM; Seyger, MM; van de Kerkhof, PC; van den Hoogen, FH; van Vlijmen-Willems, IM | 1 |
Grupper, C; Rousselet, G | 1 |
Kerl, H; Klein, G; Sandhofer, M | 1 |
25 review(s) available for methotrexate and Scleroderma, Localized
Article | Year |
---|---|
Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature.
Topics: Aged; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Mycophenolic Acid; Pulse Therapy, Drug; Scleroderma, Localized; Treatment Outcome | 2021 |
Management of morphea with systemic immunosuppressive therapies: An evidence-based review.
Topics: Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized | 2023 |
Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments.
Topics: Child; Consensus; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleroderma, Localized | 2022 |
Update on the Systemic Treatment of Pediatric Localized Scleroderma.
Topics: Antirheumatic Agents; Child; Humans; Methotrexate; Mycophenolic Acid; Phototherapy; Scleroderma, Localized | 2019 |
Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history.
Topics: Adrenal Cortex Hormones; Biomarkers; Child; Humans; Methotrexate; Mycophenolic Acid; Phototherapy; Scleroderma, Localized; Scleroderma, Systemic | 2020 |
Treatment in Juvenile Scleroderma.
Topics: Child; Humans; Methotrexate; Mycophenolic Acid; Scleroderma, Localized; Scleroderma, Systemic | 2020 |
Diagnosis and management of morphoea in children: an overview.
Topics: Abatacept; Adrenal Cortex Hormones; Child; Dermatologic Agents; Early Diagnosis; Humans; Methotrexate; Mycophenolic Acid; Recurrence; Scleroderma, Localized | 2021 |
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.
Topics: Child; Dermatologic Agents; Ficusin; Humans; Methotrexate; Photochemotherapy; Photosensitizing Agents; Scleroderma, Localized; Treatment Outcome; Ultraviolet Therapy | 2018 |
Scleroderma in children.
Topics: Child; Decision Making; Humans; Immunosuppressive Agents; Male; Methotrexate; Scleroderma, Localized; Scleroderma, Systemic | 2017 |
Remission of seizures with immunosuppressive therapy in Parry-Romberg syndrome and en coup de sabre linear scleroderma: Case report and brief review of the literature.
Topics: Brain; Child; Facial Hemiatrophy; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Remission Induction; Scleroderma, Localized; Seizures; Skin | 2018 |
Treatments and outcomes in juvenile linear scleroderma: a narrative systematic review.
Topics: Facial Hemiatrophy; Humans; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized; Steroids; Treatment Outcome; Ultraviolet Therapy | 2018 |
Consensus-based recommendations for the management of juvenile localised scleroderma.
Topics: Administration, Oral; Adolescent; Child; Combined Modality Therapy; Consensus; Disease Management; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Europe; Evidence-Based Medicine; Female; Humans; Male; Methotrexate; Phototherapy; Practice Guidelines as Topic; Prednisone; Prognosis; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome | 2019 |
Interventions for morphea.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Methotrexate; Middle Aged; Phototherapy; Prednisone; Randomized Controlled Trials as Topic; Scleroderma, Localized; Young Adult | 2019 |
Scleroderma in children: an update.
Topics: Child; Early Diagnosis; Humans; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized; Scleroderma, Systemic; Treatment Outcome | 2013 |
Update on the classification and treatment of localized scleroderma.
Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index | 2013 |
New developments in juvenile systemic and localized scleroderma.
Topics: Antibodies, Monoclonal, Humanized; Child; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Microscopic Angioscopy; Mycophenolic Acid; Scleroderma, Localized; Scleroderma, Systemic; Skin; Thermography; Tomography, Optical Coherence; Ultrasonography, Doppler; Uveitis | 2013 |
Morphea and Eosinophilic Fasciitis: An Update.
Topics: Administration, Cutaneous; Administration, Oral; Algorithms; Biopsy; Calcitriol; Dermatologic Agents; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Eosinophilia; Evidence-Based Medicine; Fasciitis; Glucocorticoids; Humans; Methotrexate; Phototherapy; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Scleroderma, Localized; Skin; Tacrolimus; Treatment Outcome; United States | 2017 |
Treatment of morphea or localized scleroderma: review of the literature.
Topics: Adrenal Cortex Hormones; Colchicine; Humans; Methotrexate; Phototherapy; Scleroderma, Localized; Tacrolimus | 2010 |
Update on morphea: part II. Outcome measures and treatment.
Topics: Adolescent; Adult; Child; Humans; Methotrexate; Mycophenolic Acid; Scleroderma, Localized; Skin; Steroids; Tacrolimus; Thermography; Treatment Outcome; Ultrasonography; Ultraviolet Therapy; Validation Studies as Topic | 2011 |
A systematic review of morphea treatments and therapeutic algorithm.
Topics: Adrenal Cortex Hormones; Algorithms; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcitriol; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Immunologic Factors; Immunosuppressive Agents; Methotrexate; PUVA Therapy; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Ultraviolet Therapy; Vitamin D | 2011 |
Eosinophilic fasciitis (Shulman disease).
Topics: Adrenal Cortex Hormones; Churg-Strauss Syndrome; Diagnosis, Differential; Edema; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fasciitis; Humans; Magnetic Resonance Imaging; Methotrexate; Rare Diseases; Scleroderma, Localized; Scleroderma, Systemic; Skin Diseases | 2012 |
Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases.
Topics: Child; Child, Preschool; Dermatologic Agents; Female; Glucocorticoids; Humans; Japan; Methotrexate; Prednisolone; Scleroderma, Localized | 2006 |
[Localized scleroderma (morphea)].
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Balneology; Child; Clinical Trials as Topic; Clobetasol; Dermatologic Agents; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Prevalence; Prognosis; PUVA Therapy; Risk Factors; Scleroderma, Localized; Sex Factors; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Morphea and localized scleroderma in children.
Topics: Adrenal Cortex Hormones; Biomarkers; Calcitriol; Child; Dermatologic Agents; Humans; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized; Scleroderma, Systemic; Skin; Ultraviolet Therapy | 1999 |
Localized morphea in children.
Topics: Child; Child, Preschool; Humans; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Methotrexate; Prognosis; Scleroderma, Localized; Skin Diseases, Vesiculobullous; Steroids | 1999 |
4 trial(s) available for methotrexate and Scleroderma, Localized
Article | Year |
---|---|
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Antirheumatic Agents; Child; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Methotrexate; Prospective Studies; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome | 2011 |
Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.
Topics: Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone; Prospective Studies; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome | 2012 |
A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
Topics: Child; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Prospective Studies; Scleroderma, Localized; Time Factors | 2012 |
Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Pilot Projects; Probability; Prospective Studies; Pulse Therapy, Drug; Risk Assessment; Scleroderma, Localized; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Ultrasonography | 2005 |
84 other study(ies) available for methotrexate and Scleroderma, Localized
Article | Year |
---|---|
Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
Topics: Adolescent; Adult; Child; Dermatologic Agents; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Color; Young Adult | 2021 |
[Linear morphea in saber coup: about a case].
Topics: Disease Progression; Female; Headache; Humans; Methotrexate; Scleroderma, Localized; Skin | 2022 |
[Analysis of clinical and imaging features of 6 cases of linear scleroderma en coup de sabre with central nervous system involvement in children].
Topics: Alopecia; Anticonvulsants; Brain; Calcinosis; Child; Drug Resistant Epilepsy; Encephalomalacia; Female; Headache; Humans; Methotrexate; Prednisone; Retrospective Studies; Scleroderma, Localized; Seizures | 2022 |
Juvenile localized scleroderma: A single-centre experience from India.
Topics: Child; Child, Preschool; Dexamethasone; Glucocorticoids; Humans; India; Methotrexate; Rare Diseases; Scleroderma, Localized | 2023 |
Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography.
Topics: Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Prospective Studies; Scleroderma, Localized; Skin; Treatment Outcome; Ultrasonography | 2023 |
A Case of Linear Scleroderma in a Young Child: A Diagnosis Easily Missed in Primary Care.
Topics: Child; Exanthema; Humans; Male; Methotrexate; Methylprednisolone; Primary Health Care; Scleroderma, Localized | 2023 |
Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Topics: Child; Chronic Disease; Female; Humans; Male; Methotrexate; Retrospective Studies; Rheumatology; Risk Factors; Scleroderma, Localized | 2023 |
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma.
Topics: Arthritis, Juvenile; Child; Consensus; Humans; Methotrexate; Prospective Studies; Scleroderma, Localized | 2020 |
Subtle erythema of the forehead.
Topics: Administration, Intravenous; Administration, Oral; Biopsy; Child; Diagnosis, Differential; Drug Therapy, Combination; Erythema; Female; Forehead; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Port-Wine Stain; Scleroderma, Localized; Treatment Outcome | 2020 |
A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea.
Topics: Adolescent; Child; Child, Preschool; Clinical Protocols; Consensus; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Methotrexate; Methylprednisolone; Retrospective Studies; Scleroderma, Localized | 2020 |
Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
Topics: Child; Female; Humans; Male; Methotrexate; Multimodal Imaging; Prospective Studies; Scleroderma, Localized; Steroids | 2020 |
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cohort Studies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Treatment Outcome; Young Adult | 2020 |
Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cross-Sectional Studies; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Recurrence; Remission Induction; Retrospective Studies; Scleroderma, Localized; Time Factors; Treatment Outcome | 2021 |
A Pediatrician's Alert: Misdiagnosis of Mixed Localized Scleroderma in a Child.
Topics: Adolescent; Anti-Inflammatory Agents; Biopsy; Delayed Diagnosis; Face; Humans; Methotrexate; Methylprednisolone Acetate; Pediatricians; Prednisolone; Scleroderma, Localized; Skin; Tacrolimus; Treatment Outcome | 2020 |
Calcinosis cutis arising in morphea: a case series.
Topics: Adrenal Cortex Hormones; Calcinosis; Child; Female; Humans; Injections, Intralesional; Methotrexate; Middle Aged; Scleroderma, Localized; Skin; Skin Diseases | 2020 |
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
Topics: Antirheumatic Agents; Child; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Methotrexate; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Thermography; Treatment Failure; Treatment Outcome | 2021 |
A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
Topics: Child; Child, Preschool; Facial Hemiatrophy; Humans; Italy; Methotrexate; Retrospective Studies; Scleroderma, Localized | 2021 |
Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
Topics: Abatacept; Adolescent; Antirheumatic Agents; Child; Cohort Studies; Female; Humans; Male; Methotrexate; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Scleroderma, Systemic; Treatment Failure; Treatment Outcome | 2021 |
Cutaneous acral myofibroma with PDGFRB mutation in a patient with linear morphea en coup de sabre.
Topics: Administration, Oral; Adult; Biopsy; Connective Tissue Diseases; Dermatologic Agents; Female; High-Throughput Nucleotide Sequencing; Humans; Methotrexate; Mutation; Myofibroma; Receptor, Platelet-Derived Growth Factor beta; Scleroderma, Localized; Skin Neoplasms; Treatment Outcome | 2021 |
Predictors of family impact of juvenile localized scleroderma.
Topics: Aged; Child; Humans; Methotrexate; Quality of Life; Retrospective Studies; Scleroderma, Localized; Surveys and Questionnaires | 2021 |
Dermatologic ultrasound in the management of childhood linear morphea.
Topics: Arm; Biopsy; Child; Dermatologic Agents; Disease Progression; Female; Humans; Hyperpigmentation; Methotrexate; Scleroderma, Localized; Skin; Subcutaneous Tissue; Ultrasonography; Ultrasonography, Interventional | 2021 |
Craniofacial linear scleroderma associated with retinal telangiectasia and exudative retinal detachment.
Topics: Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Exudates and Transudates; Facial Dermatoses; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mycophenolic Acid; Retinal Detachment; Retinal Telangiectasis; Scalp Dermatoses; Scleroderma, Localized | 2017 |
Bullous morphoea: a retrospective study.
Topics: Aged; Aged, 80 and over; Blister; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Male; Methotrexate; Rare Diseases; Retrospective Studies; Scleroderma, Localized | 2017 |
The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype).
Topics: Adolescent; Adult; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Male; Methotrexate; Nausea; Retrospective Studies; Scleroderma, Localized; Treatment Outcome | 2018 |
Successful treatment of low-dose methotrexate in combination with systemic steroids for juvenile multiple and symmetrical circumscribed morphea.
Topics: Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot; Glucocorticoids; Hand; Humans; Methotrexate; Scleroderma, Localized; Skin; Treatment Outcome | 2017 |
Inflammatory arthritis in pediatric patients with morphea.
Topics: Adolescent; Age Distribution; Arthritis; Child; Child, Preschool; Cohort Studies; Comorbidity; Female; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Pediatrics; Prognosis; Retrospective Studies; Scleroderma, Localized; Severity of Illness Index; Sex Distribution | 2018 |
Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.
Topics: Adolescent; Age of Onset; Antibodies, Antinuclear; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Glucocorticoids; Humans; Male; Medication Adherence; Methotrexate; Prognosis; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Scleroderma, Localized | 2019 |
A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil.
Topics: Dermatologic Agents; Female; Humans; Methotrexate; Middle Aged; Mycophenolic Acid; Phytotherapy; Quality of Life; Scleroderma, Localized; Treatment Outcome | 2018 |
Parry-Romberg syndrome in a patient with scleroderma.
Topics: Dermatologic Agents; Facial Hemiatrophy; Female; Humans; Methotrexate; Middle Aged; Scleroderma, Localized | 2018 |
Unilateral generalized morphea: First case report in Taiwan.
Topics: Administration, Oral; Administration, Topical; Child; Emollients; Female; Humans; Hyperpigmentation; Methotrexate; Penicillamine; Prednisolone; Scleroderma, Localized; Skin; Taiwan; Treatment Outcome | 2020 |
A Case of Pansclerotic Morphea Treated With Tocilizumab.
Topics: Antibodies, Monoclonal, Humanized; Child; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Methotrexate; Quality of Life; Scleroderma, Localized; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2019 |
Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.
Topics: Adolescent; Child; Child, Preschool; Dermatologic Agents; Drug Resistance; Female; Humans; Infant; Male; Methotrexate; Retrospective Studies; Scleroderma, Localized | 2019 |
Linear morphea overlying site of previous lichen aureus in a pediatric patient.
Topics: Administration, Oral; Administration, Topical; Biopsy, Needle; Child; Diagnosis, Differential; Drug Therapy, Combination; Exanthema; Folic Acid; Humans; Immunohistochemistry; Leg Dermatoses; Male; Methotrexate; Prognosis; Pruritus; Scleroderma, Localized; Steroids; Treatment Outcome | 2019 |
Acquired Strabismus in Linear Scleroderma of the Face.
Topics: Child; Drug Therapy, Combination; Facial Dermatoses; Female; Fixation, Ocular; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Oculomotor Muscles; Prednisone; Scleroderma, Localized; Strabismus; Treatment Outcome | 2019 |
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antirheumatic Agents; Child; Comparative Effectiveness Research; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Male; Methotrexate; Methylprednisolone; Pilot Projects; Prednisone; Prospective Studies; Rare Diseases; Scleroderma, Localized; Scleroderma, Systemic; Young Adult | 2019 |
Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.
Topics: Adult; Contrast Media; Dermatologic Agents; Female; Gadolinium DTPA; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisolone; Prospective Studies; Scleroderma, Localized; Statistics, Nonparametric; Treatment Outcome | 2013 |
Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
Topics: Adolescent; Adult; Child; Child, Preschool; Dermatologic Agents; Female; Follow-Up Studies; Humans; Male; Methotrexate; Prednisone; Remission Induction; Retrospective Studies; Scleroderma, Localized; Time Factors; Young Adult | 2013 |
Thermography for evaluation of localized scleroderma treated with methotrexate and corticosteroid.
Topics: Child; Dermatologic Agents; Female; Glucocorticoids; Humans; Leg; Methotrexate; Methylprednisolone; Prednisone; Scleroderma, Localized; Thermography | 2013 |
Hypopigmented micropapules in apparently quiescent morphea lesions: a manifestation of disease activity.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Folic Acid; Humans; Hypopigmentation; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Mycophenolic Acid; Scleroderma, Localized; Vitamin B Complex | 2013 |
Short- and long-term outcome of linear morphoea in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age of Onset; Aminoquinolines; Calcitriol; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Methotrexate; Ointments; Phototherapy; Retrospective Studies; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Vitamin A; Vitamin E | 2013 |
High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma.
Topics: Adolescent; Child; Child, Preschool; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Methotrexate; Scleroderma, Localized; Skin; Treatment Outcome; Ultrasonography | 2014 |
Headaches as a presenting symptom of linear morphea en coup de sabre.
Topics: Adolescent; Biopsy; Brain; Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Headache; Humans; Magnetic Resonance Imaging; Methotrexate; Migraine Disorders; Prednisone; Scalp; Scleroderma, Localized | 2014 |
Attitudes and trends in the treatment of morphea: a national survey.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antimalarials; Attitude of Health Personnel; Child; Data Collection; Dermatology; Humans; Methotrexate; Pediatrics; Phototherapy; Physicians; Practice Patterns, Physicians'; Professional Practice; Rheumatology; Sampling Studies; Scleroderma, Localized | 2015 |
A rare cause of gingival recession: morphea with intra-oral involvement.
Topics: Cone-Beam Computed Tomography; Female; Gingival Recession; Humans; Methotrexate; Polymerase Chain Reaction; Scleroderma, Localized; Young Adult | 2015 |
Morphea-like plaques, induration of the extremities, and eosinophilia.
Topics: Adrenal Cortex Hormones; Eosinophilia; Fasciitis; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Scleroderma, Localized | 2015 |
Case 1: Alopecia in a Healthy 9-year-old Girl.
Topics: Adrenal Cortex Hormones; Alopecia; Child; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Methotrexate; Scleroderma, Localized | 2015 |
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
Topics: Adolescent; Adult; Aged; Child; Disease Progression; Drug Resistance; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Scleroderma, Localized; Severity of Illness Index; Skin; Time Factors; Treatment Outcome; Young Adult | 2016 |
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Child; Child, Preschool; Female; Folic Acid; Humans; Infant; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Scleroderma, Localized; Treatment Outcome | 2016 |
[Generalized circumscribed scleroderma with blisters].
Topics: Administration, Oral; Administration, Topical; Biopsy; Blister; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Penicillins; Prednisolone; Recurrence; Scleroderma, Localized; Skin; Ultraviolet Therapy | 2017 |
Pediatric morphea (localized scleroderma): review of 136 patients.
Topics: Adolescent; Age of Onset; Antibodies, Antinuclear; Autoimmune Diseases; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Infant; Male; Methotrexate; Prevalence; Retrospective Studies; Risk Factors; Scleroderma, Localized; Scleroderma, Systemic; Sex Factors; Skin; White People | 2008 |
Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
Topics: Adolescent; Adolescent Medicine; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antirheumatic Agents; Child; Child, Preschool; Connective Tissue; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Penicillamine; Retrospective Studies; Scleroderma, Localized | 2008 |
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cohort Studies; Female; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Scleroderma, Localized; Time Factors; Young Adult | 2009 |
Methotrexate for sclerotic skin disorders: no evidence for effectiveness.
Topics: Dermatologic Agents; Humans; Methotrexate; Scleroderma, Localized; Treatment Outcome | 2009 |
Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
Topics: Adolescent; Child; Child, Preschool; Drug Evaluation; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Treatment Outcome | 2009 |
Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Child; Child, Preschool; Data Collection; Humans; Methotrexate; Outcome Assessment, Health Care; Pediatrics; Practice Patterns, Physicians'; Rheumatology; Scleroderma, Localized; Treatment Outcome | 2010 |
Case of localized scleroderma successfully treated with bath psoralen and ultraviolet A therapy.
Topics: Administration, Cutaneous; Ankle Joint; Baths; Child; Combined Modality Therapy; Female; Fibrosis; Ficusin; Humans; Methotrexate; Methylprednisolone; Prednisolone; PUVA Therapy; Scleroderma, Localized; Treatment Outcome | 2010 |
[Linear localized scleroderma. Successful treatment with prednisolone pulse therapy and methotrexate].
Topics: Administration, Topical; Anti-Inflammatory Agents; Autoantibodies; Biopsy; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone; Pulse Therapy, Drug; Scleroderma, Localized; Skin; Tacrolimus | 2010 |
An evaluation of long-term outcomes in adults with pediatric-onset morphea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Age of Onset; Aged; Child; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Methotrexate; Middle Aged; Recurrence; Risk Assessment; Scleroderma, Localized; Severity of Illness Index; Sex Distribution; Time Factors; Treatment Outcome; Young Adult | 2010 |
Atypical generalized morphea-like scleroderma presenting deep sclerosis on the fingers.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Fingers; Glucocorticoids; Hand Strength; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Scleroderma, Localized; Sclerosis; Treatment Outcome | 2011 |
Methotrexate in juvenile localized scleroderma: adding to the evidence.
Topics: Child; Humans; Methotrexate; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome | 2011 |
Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty.
Topics: Child; Female; Humans; Joint Diseases; Methotrexate; Methylprednisolone; Puberty, Precocious; Scleroderma, Localized; Scleroderma, Systemic; Sclerosis; Sjogren's Syndrome; Triptorelin Pamoate | 2011 |
Clinical features of childhood localized scleroderma in an incidence cohort.
Topics: Back; Child; Cohort Studies; Extremities; Face; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Scleroderma, Localized; Severity of Illness Index; Skin; Surveys and Questionnaires | 2011 |
Relapse after systemic treatment in paediatric morphoea.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Age of Onset; Analysis of Variance; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Infant; Male; Methotrexate; Recurrence; Scleroderma, Localized | 2012 |
Use of a fractional ablative 10.6-μm carbon dioxide laser in the treatment of a morphea-related contracture.
Topics: Adult; Contracture; Dermatologic Agents; Female; Humans; Lasers, Gas; Low-Level Light Therapy; Methotrexate; Scleroderma, Localized | 2011 |
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome | 2012 |
Letter: Methotrexate for localized morphea with severe pain: a case report.
Topics: Dermatologic Agents; Female; Humans; Methotrexate; Pain; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
[Localized scleroderma (morphea) in childhood].
Topics: Adolescent; Adrenal Cortex Hormones; Child; Combined Modality Therapy; Dermatologic Agents; Humans; Methotrexate; Phototherapy; Scleroderma, Localized | 2012 |
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Topics: Adolescent; Consensus; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Methylprednisolone; Practice Guidelines as Topic; Program Development; Randomized Controlled Trials as Topic; Scleroderma, Localized; Scleroderma, Systemic; Treatment Outcome; Young Adult | 2012 |
Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship?
Topics: Calcinosis; Child; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Scleroderma, Localized; Treatment Outcome | 2003 |
Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report.
Topics: Adult; Chronic Disease; Erythema; Female; Folic Acid; Glycosaminoglycans; Humans; Immunohistochemistry; Methotrexate; Myxedema; Phototherapy; Scleroderma, Localized; Skin | 2004 |
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
Topics: Adolescent; Age of Onset; Autoantibodies; Autoimmune Diseases; Child; Child, Preschool; Environment; Female; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; International Cooperation; Male; Methotrexate; Rheumatic Diseases; Risk Factors; Scleroderma, Localized | 2006 |
Treatment of pediatric localized scleroderma with methotrexate.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Retrospective Studies; Scleroderma, Localized; Treatment Outcome | 2006 |
Unilateral generalized morphea is a rare variant of localized scleroderma.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Pulse Therapy, Drug; Scleroderma, Localized; Treatment Outcome | 2006 |
Congenital localized scleroderma.
Topics: Atrophy; Biopsy; Chelating Agents; Child, Preschool; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Methotrexate; Penicillamine; Scleroderma, Localized; Skin | 2006 |
Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Topics: Adolescent; Child; Child, Preschool; Dermatologic Agents; Disease Progression; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methotrexate; Prednisolone; Recurrence; Retrospective Studies; Scleroderma, Localized; Thermography; Treatment Outcome | 2006 |
En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
Topics: Adolescent; Adult; Aged; Child; Dermatologic Agents; Disease Progression; Facial Hemiatrophy; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Scleroderma, Localized; Seizures | 2007 |
Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent.
Topics: Adolescent; Antirheumatic Agents; Child; Drug Resistance; Electroencephalography; Epilepsy; Humans; Male; Methotrexate; Scleroderma, Localized | 2008 |
[Lichen myxedematosus and scleromyxedema].
Topics: Cyclophosphamide; Humans; Lichen Planus; Male; Methotrexate; Middle Aged; Mucins; Myxedema; Scleroderma, Localized; Skin | 1982 |
Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement.
Topics: Adult; Eosinophilia; Fasciitis; Humans; Hypergammaglobulinemia; Immunoglobulin M; Kidney Diseases; Male; Methotrexate; Scleroderma, Localized | 1995 |
Progressive linear scleroderma and morphea in a child.
Topics: Child; Dermatologic Agents; Female; Humans; Methotrexate; Scleroderma, Localized | 1998 |
Methotrexate and corticosteroid therapy for pediatric localized scleroderma.
Topics: Administration, Oral; Anti-Inflammatory Agents; Child; Child, Preschool; Confidence Intervals; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Leukopenia; Male; Methotrexate; Methylprednisolone; Placebos; Recurrence; Remission Induction; Scleroderma, Localized | 2000 |
Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Topics: Adult; Dermatologic Agents; Female; Heparin; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mast Cells; Methotrexate; Middle Aged; Proteoglycans; Scleroderma, Localized; Scleroderma, Systemic; Tenascin; Treatment Outcome | 2001 |
[Pemphigus accompanied by sclerodermic-type esophageal lesions].
Topics: Deglutition Disorders; Esophageal Diseases; Female; Humans; Methotrexate; Pemphigus; Scleroderma, Localized | 1972 |
[Treatment of "collagen and autoimmune" diseases (author's transl)].
Topics: Adolescent; Adult; Aminobenzoates; Azathioprine; Chloroquine; Cyclophosphamide; Dermatomyositis; Dextrans; Female; Humans; Indomethacin; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Norethindrone; Penicillamine; Pregnanes; Scleroderma, Localized; Scleroderma, Systemic | 1973 |